BEGIN:VCALENDAR VERSION:2.0 PRODID:-//wp-events-plugin.com//7.2.3.1//EN TZID:Europe/Helsinki X-WR-TIMEZONE:Europe/Helsinki BEGIN:VEVENT UID:415@inflames.utu.fi DTSTART;TZID=Europe/Helsinki:20251002T120000 DTEND;TZID=Europe/Helsinki:20251002T130000 DTSTAMP:20250916T074856Z URL:https://inflames.utu.fi/events/frontiers-of-science-prof-olli-kallioni emi/ SUMMARY:Frontiers of Science: Prof. Olli Kallioniemi DESCRIPTION:2nd October at 12:00\nOnsite event\nin Presidentti auditorium\, BioCity\n\nProf. Olli Kallioniemi\, FIMM\, HiLife\, University of Helsink i\, Finland\nTechnology-\, data- and AI-driven translational cancer resear ch\n\nHost: Klaus Elenius (klaele@utu.fi)\n\nCoffee and sandwich served at 11:45\, first come first serve!\n\n \;\n\nSix PhD researchers and ear ly-career postdocs are welcome to have a lunch and discuss with Prof. Kall ioniemi after the seminar. This is a great possibility to learn hosting sk ills in a friendly environment and create connections for future. Everyone is welcome to join\, BioCity Turku will offer the lunch.\n\nIf you got in terested\, please send an email to biocityturku@bioscience.fi\n\n \;\n \nOlli Kallioniemi is Research Director at the Institute for Molecular Med icine Finland (FIMM)\, part of HiLIFE at the University of Helsinki. He al so holds an adjunct professorship in Molecular Precision Medicine at Karol inska Institutet.\n\nKallioniemi earned his M.D. and Ph.D.\, along with a specialization in Laboratory Medicine\, at the University of Tampere\, Fin land. He completed a postdoctoral fellowship at UC San Francisco (1990–1 992) and subsequently served as a tenure-track group leader at the NHGRI / National Institutes of Health in Bethesda\, MD (1995–2001). After recei ving tenure\, he returned to Finland to direct the Turku Medical Biotechno logy Unit of VTT/University of Turku. In 2007\, he became the founding dir ector of FIMM – the Institute for Molecular Medicine Finland at the Univ ersity of Helsinki – as part of the Nordic EMBL Partnership for Molecula r Medicine\, a role he held until 2015. From 2015 to 2024\, he served as D irector of Science for Life Laboratory (SciLifeLab\, www.scilifelab.se) in Stockholm\, Sweden’s national infrastructure for life science\, while a lso holding a professorship at Karolinska Institutet.\n\nKallioniemi’s r esearch focuses on functional and systems medicine in cancer\, with an emp hasis on technology-enabled\, data- and AI-driven precision medicine strat egies to improve diagnostics and therapy\, particularly for acute myeloid leukemia and prostate cancer. He was the founding director (2021–2025) o f a 12-year\, SEK 3.3 billion (approx. €300 million) multi-university re search program on data-driven life science (DDLS)\, funded by the Knut and Alice Wallenberg Foundation.\n\nHis current work centers on applying AI t o the analysis of molecular medicine and human health datasets\, and on de veloping translational applications of AI. This initiative is supported by the Brain Gain Research Grant from the Finnish Medical Foundations (Erkko Foundation\, Sigrid Jusélius Foundation\, and the Finnish Medical Societ y Duodecim). He also co-leads a national initiative by the Finnish Ministr y of Social Affairs and Health and SITRA to plan the future use of health data in Finland.\n\n \;\n\nSelected publications\n\nImplementing a fun ctional precision medicine tumor board for acute myeloid leukemia. By Mala ni D\, Ashwini K\, Brück O\, Kontro M P\, Bhagwan Y\, Hellesøy M\, Kuusa nmäki H\, Dufva\, O M J\, Kankainen M J\, Eldfors S\, Potdar S\, Saarela J\, Turunen L\, Parsons A O\, Västrik I\, Kivinen K\, Saarela J\, Riikka R\, Lehto M\, Wolf L-M\, Gjertsen B\, Mustjoki S\, Aittokallio T A\, Wenne rberg K\, Heckman C\, Kallioniemi O*\, Porkka K*. Cancer Discovery. 2022 F eb\;12(2):388-401.\n\nMultiomics and digital monitoring during lifestyle c hanges reveal independent dimensions of human biology and health. Marabita F\, James T\, Anu Karhu A\, Virtanen H\, Kettunen K\, Stenlund H\, Boulun d F\, Hellström C\, Neiman M\, Mills R\, Perheentupa T\, Laivuori H\, Hel kkula P\, Byrne M\, Jokinen I\, Honko H\, Kallonen A\, Ermes M\, Similä H \, Lindholm M\, Widen E\, Ripatti S\, Perälä-Heape M\, Engstrand L\, Nil sson P\, Moritz T\, Miettinen T\, Sallinen R\, Kallioniemi O. Cell Systems . 2022 Mar 16\;13(3):241-255.e7.\n\nTrac QT\, Pawitan Y\, Mou T\, Erkers T \, Östling P\, Bohlin A\, Österroos A\, Vesterlund M\, Jafari R\, Siavel is I\, Bäckvall H\, Kiviluoto S\, Orre LM\, Rantalainen M\, Lehtiö J\, L ehmann S\, Kallioniemi O\, Vu TN. Prediction model for drug response of ac ute myeloid leukemia patients. NPJ Precis Oncol. 2023 Mar 24\;7(1):32.\n\n  \;\n\nGeneral information\n\n You can download and save all the autu mn 2025 FoS-seminars to your calendar from here: https://seafile.utu.fi/d/ 44a70f80ac1e46a9ad0a/\n Registration is not needed\, participation list i s circulated in the audience\n If you are a student and later wish to get a certificate of attendance from the Frontier of Science seminars\, print out the seminar diary and after the seminar ask the BioCity coordinator t o sign it https://seafile.utu.fi/d/44a70f80ac1e46a9ad0a/\n Please note th at any audio or video recording of the seminars is strictly forbidden.\n Autumn 2025 image credits to Kari Kaunisto: Sahlberg family collections\, Biodiversity unit\, University of Turku\n\n \; ATTACH;FMTTYPE=image/jpeg:https://inflames.utu.fi/wp-content/uploads/kalli oniemi-500px.jpg CATEGORIES:Events in English,Tapahtumat END:VEVENT BEGIN:VTIMEZONE TZID:Europe/Helsinki X-LIC-LOCATION:Europe/Helsinki BEGIN:DAYLIGHT DTSTART:20250330T040000 TZOFFSETFROM:+0200 TZOFFSETTO:+0300 TZNAME:EEST END:DAYLIGHT END:VTIMEZONE END:VCALENDAR